Cincinnati, OH (PRWEB) January 28, 2009
Cognis Corporation, through its QTA® System business, has introduced QTA On-Demand to address the needs of biodiesel plants looking for a more effective quality and process testing approach. Using the proven QTA System technology found in some of the world's largest biodiesel plants, QTA is now offering the same testing approach on a per sample, on-demand basis. With results up to a week faster at less than half the cost of full ASTM lab service, QTA On-Demand is a cost effective way for facilities with a smaller sample load to get the accuracy and reliability of a full QTA System.
Barbara Stefl, Cognis' Global Business Director, said, "While plants all over the world use our QTA System to keep their B100 in spec, the level of investment does not always make sense for every plant. Now, with QTA On-Demand, smaller plants or ones just starting up can take advantage of the accuracy and fast turnaround of the QTA System's patented approach to biodiesel quality testing on an as-needed basis."
QTA's On-Demand Service starts with plant personnel taking an as-is B100 or incoming feedstock sample and sending it to Cognis' QTA. We then collect the light spectra of the sample, without further preparation, using proven infrared technology. Those spectra are then converted into industry standard quality measurements via Cognis' patented algorithms--called Chingometrics™. Results are then e-mailed to the customer--all in less than 24 hours after the sample is received.
QTA On-Demand measures all of the parameters needed to assess the quality of each batch of B100, including Free and Total Glycerin, Acid Number, Cloud Point, Moisture and Methanol content. It can also provide information on in-process samples needed for process control, for incoming oil or crude glycerin analyses.
QTA® is a service business of Cognis Corporation -a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,700 people, and it operates production sites and service centers in 30 countries. Cognis' QTA® business provides on-site, ready-to-use analytical capabilities without additional investment in equipment or personnel. Patented, centralized calibration technology enhances accuracy. For more information on the QTA® system, visit http://www.qta.com
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2006, Cognis recorded sales of 3.37 billion euros and an Adjusted EBITDA (operating result) of 394 million euros.